Comparison of the Bordetella pertussis and Bordetella parapertussis isolates circulating in Saint Petersburg between 1998 and 2000 with Russian vaccine strains

Journal of Clinical Microbiology

Volumn 41, Issue 8, 2003, Pages 3706-3711

  Kourova, Natacha ^a   Caro, Valérie ^b   Weber, Christian ^b   Thiberge, Sabine ^b   Chuprinina, Raisa ^c   Tseneva, Galina ^a   Guiso, Nicole ^b  

^a ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^b INSTITUT PASTEUR   (France)

^c L A T Stt Ctrl/Std Inst   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL VACCINE; PERTACTIN; PERTUSSIS TOXIN;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC CODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PRN GENE; PTXS1 GENE; PULSED FIELD GEL ELECTROPHORESIS; RUSSIAN FEDERATION; SEROTYPING; SPEI GENE; STRAIN DIFFERENCE; XBAI GENE;

ADENYLATE CYCLASE; ANIMALS; BORDETELLA; BORDETELLA PERTUSSIS; CYCLIC AMP; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; INCIDENCE; MICE; MICE, INBRED BALB C; PERTUSSIS VACCINE; PHYLOGENY; POLYMORPHISM, GENETIC; RUSSIA; URBAN POPULATION; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; NEGIBACTERIA;

EID: 0042023392     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.8.3706-3711.2003     Document Type: Article

References (23)

1. Baron, S., E. Njamkepo, E. Grimprel, P. Begue, J. C. Desenclos, J. Drucker, and N. Guiso. 1998. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr. Infect. Dis. J. 17:412-418.
2. Boursaux-Eude, C., and N. Guiso. 2000. Polymorphism of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica. Infect. Immun. 68:4815-4817.
3. Crowcroft, N. S., N. Andrews, C. Rooney, M. Brisson, and E. Miller. 2002. Deaths from pertussis are underestimated in England. Arch. Dis. Child. 86:336-338.
4. Floret, D., Groupe de Pathologie Infectieuse Pédiatrique, and Groupe Francophone de Réanimation et d'Urgence Pédiatrique. 2001. Les décès par infection bactérienne communautaire. Enquête dans les services de réanimation pédiatrique français. Arch. Pédiatr. 8:705-711.
5. Grimprel, E., S. Baron, D. Levy-Bruhl, J. M. Garnier, E. Njamkepo, N. Guiso, and P. Bégué. 1999. Influence of vaccination coverage on pertussis transmission in France. Lancet 354:1699-1700.
6. Gzyl, A., E. Augustynowicz, I. Van Loo, and J. Slusarczyk. 2002. Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland. Vaccine 20:299-303.
7. Hardwick, T. H., P. Cassiday, R. S. Weyant, K. M. Bisgard, and G. N. Sanden. 2002. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg. Infect. Dis. 8:44-49.
8. He, Q. S., M. K. Viljanen, H. Arvilommi, B. Aittanen, and J. Mertsola. 1998. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA. 280:635-637.
9. Khattak, M. N., R. C. Matthews, and J. P. Burnie. 1992. Is Bordetella pertussis clonal? Br. Med. J. 304:813-815.
10. Ladant, D., C. Brezin, J.-M. Alonso, I. Crenon, and N. Guiso. 1986. Bordetella pertussis adenylate cyclase. Purification, characterization, and radioimmunoassay. J. Biol. Chem. 261:16264-16269.
11. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
12. Li, L. J., G. Dougan, P. Novotny, and I. G. Charles. 1991. P. 70 pertactin, an outer-membrane protein from Bordetella parapertussis: cloning, nucleotide sequence and surface expression in Escherichia coli. Mol. Microbiol. 5:409-417.
13. Mastrantonio, P., P. Spigaglia, H. van Oirschot, H. G. J. van der Heide, K. Heuvelman, P. Stefanelli, and F. R. Mooi. 1999. Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 145:2069-2075.
14. Mattoo, S., A. K. Foreman-Wykert, P. A. Cotter, and J. F. Miller. 2001. Mechanisms of Bordetella pathogenesis. Front. Biosci. 6:1.
15. Mooi, F. R., H. Hallander, C. H. Wirsing von Köning, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. Clin. Infect. Dis. J. 19:174-181.
16. Mooi, F. R., H. Qiushui, H. van Oirschot, and J. Mertsola. 1999. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect. Immun. 67:3133-3134.
17. Mooi, F. R., H. van Oirschot, K. Heuvelman, H. G. J. van der Heide, W. Gaastra, and R. J. L. Willems. 1998. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66: 670-675.
18. Njamkepo, E., F. Rimlinger, S. Thiberge, and N. Guiso. 2002. Thirty-five years' experience with the whole-cell pertussis vaccine in France: vaccine strains analysis and immunogenicity. Vaccine 20:1290-1294.
19. Register, K. B. 2001. Novel genetic and phenotypic heterogeneity in Bordetella bronchiseptica pertactin. Infect. Immun. 69:1917-1921.
20. Rohani, P., D. J. D. Earn, and B. T. Grenfell. 1999. Opposite patterns of synchrony in sympatric disease metapopulations. Science 286:968-971.
21. Saitou, N., and M. Nei. 1987. A new method for reconstructing phylogenetic tree. Mol. Biol. Evol. 4:406-425.
22. van Loo, I. H. M., H. G. J. van der Heide, N. J. D. Nagelkerke, J. Verhoef, and F. R. Mooi. 1999. Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population. J. Infect. Dis. 179:915-923.
23. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating in the last ten years in France, where a single effective whole-cell vaccine has been used for more than thirty years. J. Clin. Microbiol. 39:4396-4403.